Open AccessThe first Russian experience with the endothelin 1 receptor inhibitor traclir used in patients with pulmonary hypertension associated with systemic connective tissue diseases
Author(s) -
Aleksandr Vitalyevich Volkov,
T. V. Martynyuk,
N. N. Yudkina,
N. M. Danilov,
T M Reshetnyak,
И Е Чазова,
E L Nasonov
Publication year - 2011
Publication title -
rheumatology science and practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.137
H-Index - 9
eISSN - 1995-4492
pISSN - 1995-4484
DOI - 10.14412/1995-4484-2011-515
Subject(s) - pulmonary hypertension , endothelin receptor , medicine , connective tissue , endothelin 1 , systemic circulation , pathology , cardiology , receptor
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom